BACKGROUND: Genetic variants in TNNI3K (troponin-I interacting kinase) have previously been associated with dilated cardiomyopathy (DCM), cardiac conduction disease, and supraventricular tachycardias. However, the link between TNNI3K variants and these cardiac phenotypes shows a lack of consensus concerning phenotype and protein function. METHODS: We describe a systematic retrospective study of a cohort of patients undergoing genetic testing for cardiac arrhythmias and cardiomyopathy including TNNI3K . We further performed burden testing of TNNI3K in the UK Biobank. For 2 novel TNNI3K variants, we tested cosegregation. TNNI3K kinase function was estimated by TNNI3K autophosphorylation assays. RESULTS: We demonstrate enrichment of rare coding TNNI3K variants in DCM patients in the Amsterdam cohort. In the UK Biobank, we observed an association between TNNI3K missense (but not loss-of-function) variants and DCM and atrial fibrillation. Furthermore, we demonstrate genetic segregation for 2 rare variants, TNNI3K-p.Ile512Thr and TNNI3K-p.His592Tyr, with phenotypes consisting of DCM, cardiac conduction disease, and supraventricular tachycardia, together with increased autophosphorylation. In contrast, TNNI3K-p.Arg556_Asn590del, a likely benign variant, demonstrated depleted autophosphorylation. CONCLUSIONS: Our findings demonstrate an increased burden of rare coding TNNI3K variants in cardiac patients with DCM. Furthermore, we present 2 novel likely pathogenic TNNI3K variants with increased autophosphorylation, suggesting that enhanced autophosphorylation is likely to drive pathogenicity.

No abstract

No abstract

Device displacement with pulmonary artery embolisation (PDA) is a rare complication after percutaneous closure of a patent arterial duct. An 11-day old neonate with PDA was admitted to the Department of Paediatric Cardiac Surgery for treatment. The newborn was qualified for a transcatheter closure of PDA. Device displacement to the pulmonary artery was observed during the procedure. The patient was qualified for a surgical procedure of PDA closure, with removal of the implant via midline sternotomy to provide an additional safeguard with extracorporeal circulation. The procedure and early postoperative course were uneventful. The patient was discharged home in good general condition. Interventional cardiology can provide effective minimally-invasive solutions for congenital heart disease treatment, but there is always a risk of potentially life-threatening complications.